24th Annual Summer Seminars: The Treatment of Major Depression and Anxiety Disorders: Integrating Psychopharmacology and Psychotherapeutic Strategies in Clinical
Russell G. Vasile, MD
The objective of this seminar is to familiarize the clinician with emerging strategies in the assessment and treatment of major depression, bipolar illness and anxiety disorders. The course will also highlight key co-morbid conditions associated with mood and anxiety disorders, including axis II personality disorders, management of patients with medical conditions and management of the geriatric patient. An essential theme of the program will be formulating an integrated psychopharmacologic and psychotherapeutic treatment approach. The psychotherapy of the mood and/or anxiety disorder patient, including those with co-morbid personality disorder will be examined in detail. Issues around the choice of specific antidepressants, mood stabilizers and anti-anxiety medications and psychopharmacologic management of the treatment resistant patient will be highlighted with a discussion of the use of augmenting medication strategies and combinations of psychopharmacologic agents. The role of electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) will be examined. Psychotherapeutic approaches to mood and anxiety disorders will be studied with a focus on differing strategies including psychodynamic psychotherapy, cognitive and behavioral therapy, interpersonal psychotherapy for depression and other psychotherapeutic approaches. The seminar will update the clinician on recent developments in neuropsychiatry, including brain imaging and therapeutic stimulation techniques.
- Describe emerging strategies in the use of psychotropic medications in the treatment of major depression and anxiety disorders;
- Demonstrate the integration of appropriate psychopharmacologic treatments into a comprehensive treatment plan, including psychodynamic, cognitive and behavioral psychotherapies;
- Describe the diagnosis and treatment of affective disorders, including depression and manic depressive illness, anxiety disorders and personality disorders;
- Analyze diagnostic and treatment strategies across the life cycle, with particular attention to issues in psychopharmacologic management of the geriatric population and patients with medical illness;
- Use integrated psychopharmacologic and psychotherapeutic strategies in the treatment of refractory patients, including those with co-morbid depression and/or anxiety disorders and personality disorder;
- Describe the use of newly emerging strategies in the assessment and treatment of major depression and anxiety disorders, including brain-imaging techniques, and the use of therapeutic brain stimulation techniques including vagal nerve stimulation and transcranial magnetic stimulation.
Warning: Invalid argument supplied for foreach() in /nfs/c10/h13/mnt/150145/domains/continuingeducationprogram.org/html/wp-content/themes/bidmc/single-courses.php on line 110
Monday – Friday: 9:00 am – 12:15 PM
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.
Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School continuing education is an NBCC Approved Continuing Provider (ACEP) and may offer NBCC approved clock hours for events that meet NBCC requirements. The Week Long Summer Seminars for a maximum of 15 clock hours and the Weekend Summer Seminars for a maximum of 10 clock hours. The ACEP solely is responsible for all aspects of the program.
Social Workers: For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: email@example.com.
Nurses: Beth Israel Deaconess Medical Center Nursing Education is an approved provider of continuing nursing education by the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Beth Israel Deaconess Medical Center Nursing Education will provide contact hours for the The Treatment of Major Depression and Anxiety Disorders: Integrating Psychopharmacology and Psychotherapeutic Strategies in Clinical Practice. This summer program meets the specifications of the Board of Registration in Nursing (244 CMR).
RUSSELL G. VASILE, MD is an Associate Professor of Psychiatry, Harvard Medical School and Director of the Affective Disorders Consultation Program at the Beth Israel Deaconess Medical Center. Dr. Vasile has published in diverse areas related to the assessment and treatment of anxiety and affective disorders. Dr. Vasile is a graduate of the Boston Psychoanalytic Society and Institute, and is certified in Forensic Psychiatry. He is a past recipient of the Elvin V. Semrad Award for Excellence in Teaching at the Massachusetts Mental Health Center.